Target intelligence / Profile preview

T cell receptor beta variable 6 (TRBV6) (TRBV6)

Target
TRBV6
Molecular classification
Receptor, Immunoglobulin superfamily protein
01

Overview

The **T cell receptor beta variable 6** (**TRBV6**) is one member of a family of gene segments encoding the variable region of the β chain in αβ T cell receptors. The **T cell receptor** is a heterodimeric membrane-bound protein complex found on most mature T lymphocytes. It consists typically of an alpha and a beta chain, each with highly diverse variable regions generated through somatic recombination involving multiple gene segments—variable (**V**), diversity (**D**, only for β), and joining (**J**)—and random nucleotide insertions/deletions at their junctions. The **Vβ6** designation refers specifically to one subgroup within the large set (~48) of human β-chain variable region genes. The primary function of any given **TCR β-chain**, including those encoded by TRBV6, is to contribute to antigen specificity by forming part of the antigen-binding site that recognizes peptide fragments presented by major histocompatibility complex molecules on other cells. The complementarity-determining region 3 (**CDR3**) within this domain is especially important for determining binding specificity due to its high sequence variability resulting from recombination events. While there are no approved drugs that specifically target or modulate individual Vβ families such as TRBV6, understanding their distribution can be important in research settings—for example, tracking clonal expansions during infection or cancer immunotherapy. Engineered cellular therapies may utilize defined Vα/Vβ combinations for targeted recognition. In summary, **T cell receptor beta variable 6** is an essential component contributing to antigen recognition diversity among αβ T cells—a key element enabling adaptive immunity's breadth and specificity.

Other names
TCR Vβ6TRBV6 familyT cell receptor beta variable chain Vβ6
02

Biological functions

Antigen recognition by T cellsSignal transduction in adaptive immunityImmune response mediation
03

Disease associations

Cancer (as part of tumor-infiltrating lymphocytes and immunotherapy targets)Infection (recognition of pathogen-derived peptides)Autoimmune disease (implicated in aberrant immune responses)

Beyond the preview

Go deeper on T cell receptor beta variable 6 (TRBV6) (TRBV6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 6 (TRBV6) (TRBV6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call